Julia Baller
Research Subjects
Julia Baller has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Denise Juliano-Bult
National Institute of Mental Health, Bethesda, MD, USA
2 shared publications - Gail Lois Daumit
Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 shared publications - Susan T. Azrin
Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, Maryland
2 shared publications - Emma E McGinty
Johns Hopkins Bloomberg School of Public Health, 624 N Broadway St., Room 405, Baltimore, MD, 21205, USA
1 shared publication - Emma Elizabeth McGinty
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
1 shared publication
Latest Publications
- 1 July 2015
- Published by Elsevier in Schizophrenia Research
- Vol. 165 (2-3) , 227-235
Quality of medical care for persons with serious mental illness: A comprehensive review
- 1 July 2015
- Published by Elsevier in Schizophrenia Research
- Vol. 165 (2-3) , 227-235
Quality of medical care for persons with serious mental illness: A comprehensive review
- Open Access
- 21 March 2015
- Published by Springer Nature in BMC Psychiatry
- Vol. 15 (1) , 1-13
Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence
Adults with serious mental illness have a mortality rate two to three times higher than the overall US population, much of which is due to somatic conditions, especially cardiovascular disease. Given the disproportionately high prevalence of cardiovascular risk factors in the population with SMI, screening for these conditions is an important first step for timely diagnosis and appropriate treatment. This comprehensive literature review summarizes screening rates for cardiovascular risk factors in the population with serious mental illness. Relevant articles published between 2000 and 2013 were identified using the EMBASE, PsychInfo, PubMed, SCOPUS and Web of Science databases. We reviewed 10 studies measuring screening rates for obesity, diabetes, dyslipidemia, and hypertension in the population with serious mental illness. Two reviewers independently extracted information on screening rates, study population, and study setting. Rates of screening varied considerably by time period, study population, and data source for all medical conditions. For example, rates of lipid testing for antipsychotic users ranged from 6% to 85%. For some conditions, rates of screening were consistently high. For example, screening rates for hypertension ranged from 79% - 88%. There is considerable variation in screening of cardiovascular risk factors in the population with serious mental illness, with significant need for improvement in some study populations and settings. Implementation of standard screening protocols triggered by diagnosis of serious mental illness or antipsychotic use may be promising avenues for ensuring timely diagnosis and treatment of cardiovascular risk factors in this population.
- 21 March 2015
- Published by Springer Nature in BMC Psychiatry
- Vol. 15 (1) , 1-13
Open AccessScreening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence
Adults with serious mental illness have a mortality rate two to three times higher than the overall US population, much of which is due to somatic conditions, especially cardiovascular disease. Given the disproportionately high prevalence of cardiovascular risk factors in the population with SMI, screening for these conditions is an important first step for timely diagnosis and appropriate treatment. This comprehensive literature review summarizes screening rates for cardiovascular risk factors in the population with serious mental illness. Relevant articles published between 2000 and 2013 were identified using the EMBASE, PsychInfo, PubMed, SCOPUS and Web of Science databases. We reviewed 10 studies measuring screening rates for obesity, diabetes, dyslipidemia, and hypertension in the population with serious mental illness. Two reviewers independently extracted information on screening rates, study population, and study setting. Rates of screening varied considerably by time period, study population, and data source for all medical conditions. For example, rates of lipid testing for antipsychotic users ranged from 6% to 85%. For some conditions, rates of screening were consistently high. For example, screening rates for hypertension ranged from 79% - 88%. There is considerable variation in screening of cardiovascular risk factors in the population with serious mental illness, with significant need for improvement in some study populations and settings. Implementation of standard screening protocols triggered by diagnosis of serious mental illness or antipsychotic use may be promising avenues for ensuring timely diagnosis and treatment of cardiovascular risk factors in this population.